<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR10">
 <label>10.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lester</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Neyarapally</surname>
    <given-names>GA</given-names>
   </name>
   <name>
    <surname>Lipowski</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Graham</surname>
    <given-names>CF</given-names>
   </name>
   <name>
    <surname>Hall</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Dal</surname>
    <given-names>PG</given-names>
   </name>
  </person-group>
  <article-title>Evaluation of FDA safety-related drug label changes in 2010</article-title>
  <source>Pharmacoepidemiol Drug Saf.</source>
  <year>2013</year>
  <volume>22</volume>
  <issue>3</issue>
  <fpage>302</fpage>
  <lpage>305</lpage>
  <pub-id pub-id-type="doi">10.1002/pds.3395</pub-id>
  <?supplied-pmid 23280652?>
  <pub-id pub-id-type="pmid">23280652</pub-id>
 </element-citation>
</ref>
